2-(5-tert-butyl-2-methylfuran-3-yl)-N-(4-(6-(morpholinomethyl)pyridin-3-yl)naphthalen-1-yl)-2-oxoacetamide | 848150-35-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-(5-tert-butyl-2-methylfuran-3-yl)-N-(4-(6-(morpholinomethyl)pyridin-3-yl)naphthalen-1-yl)-2-oxoacetamide
• 英文别名: 2-(5-tert-butyl-2-methylfuran-3-yl)-N-[4-[6-(morpholin-4-ylmethyl)pyridin-3-yl]naphthalen-1-yl]-2-oxoacetamide
• CAS: 848150-35-6
• 化学式: C₃₁H₃₃N₃O₄
• 分子量: 511.621
• InChiKey: GXUAESATMIDZDL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  38
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  84.7
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  N-(4-bromonaphthalen-1-yl)-2-(5-tert-butyl-2-methylfuran-3-yl)-2-oxoacetamide 、 4-(5-Tri-butylstannanyl-pyridin-2-ylmethyl)-morpholine 在 palladium diacetate 、 caesium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 作用下， 以 甲苯 为溶剂， 反应 16.0h， 生成 2-(5-tert-butyl-2-methylfuran-3-yl)-N-(4-(6-(morpholinomethyl)pyridin-3-yl)naphthalen-1-yl)-2-oxoacetamide
  参考文献：
  名称：

  ‘Reverse’ α-ketoamide-based p38 MAP kinase inhibitors

  摘要：

  We have identified a second series of potent p38 inhibitors. As with our first generation series, these compounds are based on an alpha-ketoamide scaffold. The reversal of the ketoamide order, however, introduces more chemical flexibility and in addition results in improve potencies against p38. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.09.028

文献信息

• CYTOKINE INHIBITORS
  申请人：Boman Erik

  公开号：US20100093734A1

  公开（公告）日：2010-04-15

  The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.

  本发明提供了低分子量化合物，可用作细胞因子抑制剂及其组合物。特别是，本发明的化合物可用作抗炎剂。还提供了制备这种药剂的方法，以及其在预防或治疗由细胞因子介导的疾病，如关节炎方面的用途。
• Cytokine inhibitors
  申请人：Boman Erik

  公开号：US20050107399A1

  公开（公告）日：2005-05-19

  The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis.

  本发明提供了低分子量化合物，作为细胞因子抑制剂以及其组合物。特别地，本发明的化合物可用作抗炎剂。此外，还提供了制备这些药剂的方法，并将它们用于预防或治疗由细胞因子介导的疾病，例如关节炎。
• ALPHA-KETOAMIDES AND DERIVATIVES THEREOF
  申请人：Boman Erik

  公开号：US20100273797A1

  公开（公告）日：2010-10-28

  The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions medicated by cytokines such as arthritis.

  本发明提供了低分子量化合物，可用作细胞因子抑制剂及其组合物。特别地，本发明的化合物可用作抗炎剂。还提供了制备这些药剂的方法，并将其用于预防或治疗由细胞因子介导的疾病，例如关节炎。
• EP1670787A4
  申请人：——

  公开号：EP1670787A4

  公开（公告）日：2009-04-22
• THERAPY USING CYTOKINE INHIBITORS
  申请人：Kemia, INC.

  公开号：EP2035005A2

  公开（公告）日：2009-03-18